Beta-Amyloid (35-42) carries a C-terminal hydrophobic segment critical for fibril stabilization. The peptide's structural rigidity supports exploration of aggregation thresholds and intermolecular alignment. Its behavior under controlled conditions offers insight into β-sheet propagation. Researchers use it to study amyloid formation dynamics, molecular packing, and sequence-dependent assembly.
CAT No: A13354
Synonyms/Alias:beta-Amyloid (35-42);183292-41-3;(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]propanoic acid;HY-P1903;MS-31301;CS-0097993;G13243;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More